ASHLEY MERLATI: Open Payments
NPI 1487907127 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$450 in 19 payments from 7 companies in 2025. Trend: 2023 $440 · 2024 $270 · 2025 $450
Food & beverage: $350Education: $100
| Company | Payments | Amount |
|---|---|---|
| Evofem Biosciences, Inc. | 10 | $188 |
| Astellas Pharma US Inc | 2 | $126 |
| MAYNE PHARMA COMMERCIAL LLC | 3 | $57 |
| Hologic Sales and Service, LLC | 1 | $25 |
| MILLICENT US INC | 1 | $20 |
| Sumitomo Pharma America, Inc. | 1 | $18 |
| Boston Scientific Corporation | 1 | $14 |
Products named: Phexxi, Veozah, THINPREP 2000 PROCESSOR, FEMLYV, MYFEMBREE, Bulkamid.
Industry payments across MO — which companies pay providers there.
